1.Zilversmit, DB (1979) Atherogenesis: a postprandial phenomenon. Circulation 60, 473–485.
2.Jackson, KG, Poppitt, SD & Minihane, AM (2012) Postprandial lipemia and cardiovascular disease risk: interrelationships between dietary, physiological and genetic determinants. Atherosclerosis 220, 22–33.
3.Mamo, JC & Wheeler, JR (1994) Chylomicrons or their remnants penetrate rabbit thoracic aorta as efficiently as do smaller macromolecules, including low-density lipoprotein, high-density lipoprotein, and albumin. Coron Artery Dis 5, 695–705.
4.Bentley, C, Hathaway, N, Widdows, J, et al. (2011) Influence of chylomicron remnants on human monocyte activation in vitro. Nutr Metab Cardiovasc Dis 21, 871–878.
5.Wilhelm, MG & Cooper, AD (2003) Induction of atherosclerosis by human chylomicron remnants: a hypothesis. J Atheroscler Thromb 10, 132–139.
6.Cohen, JC, Noakes, TD & Benade, AJ (1988) Serum triglyceride responses to fatty meals: effects of meal fat content. Am J Clin Nutr 47, 825–827.
7.Dubois, C, Beaumier, G, Juhel, C, et al. (1998) Effects of graded amounts (0–50 g) of dietary fat on postprandial lipemia and lipoproteins in normolipidemic adults. Am J Clin Nutr 67, 31–38.
8.Lopez-Miranda, J, Williams, C & Lairon, D (2007) Dietary, physiological, genetic and pathological influences on postprandial lipid metabolism. Br J Nutr 98, 458.
9.Batt, KV, Avella, M, Moore, EH, et al. (2004) Differential effects of low-density lipoprotein and chylomicron remnants on lipid accumulation in human macrophages. Exp Biol Med 229, 528–537.
10.Tomono, S, Kawazu, S, Kato, N, et al. (1994) Uptake of remnant like particles (RLP) in diabetic patients from mouse peritoneal macrophages. J Atheroscler Thromb 1, 98–102.
11.Yu, KC & Mamo, JC (1997) Regulation of cholesterol synthesis and esterification in primary cultures of macrophages following uptake of chylomicron remnants. Biochem Mol Biol Int 41, 33–39.
12.Schwartz, EA & Reaven, PD (2012) Lipolysis of triglyceride-rich lipoproteins, vascular inflammation, and atherosclerosis. Biochim Biophys Acta 1821, 858–866.
13.Mamo, JC, Watts, GF, Barrett, PH, et al. (2001) Postprandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression? Am J Physiol Endocrinol Metab 281, E626–E632.
14.Curtin, A, Deegan, P, Owens, D, et al. (1996) Elevated triglyceride-rich lipoproteins in diabetes. A study of apolipoprotein B-48. Acta Diabet 33, 205–210.
15.Mangat, R, Su, JW, Lambert, JE, et al. (2011) Increased risk of cardiovascular disease in Type 1 diabetes: arterial exposure to remnant lipoproteins leads to enhanced deposition of cholesterol and binding to glycated extracellular matrix proteoglycans. Diabet Med 28, 61–72.
16.Hayashi, H, Fujimoto, K, Cardelli, JA, et al. (1990) Fat feeding increases size, but not number, of chylomicrons produced by small intestine. Am J Physiol 259, G709–G719.
17.Martins, IJ, Sainsbury, AJ, Mamo, JC, et al. (1994) Lipid and apolipoprotein B48 transport in mesenteric lymph and the effect of hyperphagia on the clearance of chylomicron-like emulsions in insulin-deficient rats. Diabetologia 37, 238–246.
18.James, AP, Slivkoff-Clark, K & Mamo, JC (2003) New insights into cardiovascular disease risk in subjects with visceral obesity. Asia Pac J Public Health 15, Suppl., S37–S40.
19.Karpe, F (1997) Effects of diet on postprandial lipaemia – a suggestion for methodological standardization. Nutr Metab Cardiovasc Dis 7, 44–55.
20.Slivkoff-Clark, K, James, AP, Kerr, D, et al. (2004) The effect of diet standardisation on postprandial chylomicron response. Asia Pac J Clin Nutr 13, S69.
21.Whiteford, J, Ackland, TR, Dhaliwal, SS, et al. (2010) Effects of a 1-year randomized controlled trial of resistance training on lower limb bone and muscle structure and function in older men. Osteoporos Int 21, 1529–1536.
22.Havel, RJ, Eder, HA & Bragdon, JH (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34, 1345–1353.
23.Bairaktari, E, Hatzidimou, K, Tzallas, C, et al. (2000) Estimation of LDL cholesterol based on the Friedewald formula and on apo B levels. Clin Biochem 33, 549–555.
24.Kinoshita, M, Kojima, M, Matsushima, T, et al. (2005) Determination of apolipoprotein B-48 in serum by a sandwich ELISA. Clin Chim Acta 351, 115–120.
25.Park, Y, Damron, BD, Miles, JM, et al. (2001) Measurement of human chylomicron triglyceride clearance with a labeled commercial lipid emulsion. Lipids 36, 115–120.
26.Cohn, JS, Marcoux, C & Davignon, J (1999) Detection, quantification, and characterization of potentially atherogenic triglyceride-rich remnant lipoproteins. Arterioscler Thromb Vasc Biol 19, 2474–2486.
27.Karpe, F, Bickerton, AS, Hodson, L, et al. (2007) Removal of triacylglycerols from chylomicrons and VLDL by capillary beds: the basis of lipoprotein remnant formation. Biochem Soc Trans 35, 472–476.
28.Murphy, MC, Isherwood, SG, Sethi, S, et al. (1995) Postprandial lipid and hormone responses to meals of varying fat contents: modulatory role of lipoprotein lipase? Eur J Clin Nutr 49, 578–588.
29.Shishehbor, F, Roche, HM & Gibney, MJ (1999) The effect of low and moderate fat intakes on the postprandial lipaemic and hormonal responses in healthy volunteers. Br J Nutr 81, 25–30.
30.Gibney, MJ & Daly, E (1994) The incorporation of n-3 polyunsaturated fatty acids into plasma lipid and lipoprotein fractions in the postprandial phase in healthy volunteers. Eur J Clin Nutr 48, 866–872.